Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.

Blood
Martin A ChampagneChildren's Oncology Group phase 1 study

Abstract

The purpose of this study was to determine dose-limiting toxicities and pharmacokinetics of imatinib in children with refractory or recurrent Philadelphia chromosome-positive (Ph(+)) leukemias. Oral imatinib was administered daily at dose levels ranging from 260 to 570 mg/m(2). Plasma pharmacokinetic studies were performed on days 1 and 8 of course 1. There were 31 children who received 479 courses of imatinib. The most common toxicities encountered, which occurred in less than 5% of courses, were grade 1 or 2 nausea, vomiting, fatigue, diarrhea, and reversible increases in serum transaminases. One patient at the 440-mg/m(2) dose level had dose-limiting weight gain. There were no other first-course dose-limiting toxicities. A maximum tolerated dosage was not defined. Among 12 chronic myeloid leukemia (CML) patients evaluable for cytogenetic response, 10 had a complete response and 1 had a partial response. Among 10 acute lymphoblastic leukemia (ALL) patients evaluable for morphologic response, 7 achieved an M1 and 1 achieved an M2 bone marrow. We observed marked interpatient variability in the pharmacokinetic parameters. In conclusion, we found that daily oral imatinib is well tolerated in children at doses ranging from 260 to ...Continue Reading

Associated Clinical Trials

References

May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S GamisN K Ramsay
May 1, 1996·The American Journal of Medicine·J E CortesH Kantarjian
Oct 1, 1996·Journal of Pharmacokinetics and Biopharmaceutics·G R Wilkinson
Apr 6, 2000·The New England Journal of Medicine·M AricòG Masera
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
Mar 1, 2002·The New England Journal of Medicine·David G Savage, Karen H Antman
Mar 13, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·R BakhtiarF Tse
Jul 18, 2002·Nature Reviews. Drug Discovery·Renaud CapdevilleAlex Matter
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Apr 26, 2003·Blood·Kate CwynarskiUNKNOWN Paediatric and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bin PengRenaud Capdeville

❮ Previous
Next ❯

Citations

Dec 17, 2008·Pediatric Radiology·Peter C Adamson
Apr 10, 2008·Cancer Chemotherapy and Pharmacology·Divya Menon-AndersenJeffrey S Barrett
Mar 8, 2012·Current Hematologic Malignancy Reports·Meinolf SuttorpFrederic Millot
Jan 15, 2011·International Journal of Hematology·Hideki MuramatsuSeiji Kojima
Feb 3, 2007·Nature Reviews. Drug Discovery·Ching-Hon Pui, Sima Jeha
Feb 12, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CalafioreA Garaventa
Oct 4, 2005·The Cancer Journal·Peter C Adamson, Susan M Blaney
May 2, 2012·Journal of Pediatric Hematology/oncology·Katherine A Janeway, Alberto Pappo
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Narasimhan P AgaramCristina R Antonescu
Jan 3, 2012·Blood·Jeffrey R AndolinaSeth J Corey
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirk R SchultzBruce Camitta
Dec 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Bernadette Anna Sophia JaegerMeinolf Suttorp
Sep 29, 2011·The Oncologist·Alberuni M ZamahMitchell P Rosen
Dec 2, 2014·Pediatric Clinics of North America·Nobuko HijiyaMeinolf Suttorp
Nov 26, 2014·South Asian Journal of Cancer·Vijay Gandhi LingaAshwani Tandon
May 18, 2010·Expert Review of Anticancer Therapy·Philippe A Cassier, Jean-Yves Blay
Apr 22, 2008·Expert Opinion on Pharmacotherapy·Philippe A CassierJean-Yves Blay
Oct 24, 2007·Cancer Investigation·Jeffrey M Skolnik, Peter C Adamson
Oct 9, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Dominik Wolf, Holger Rumpold
Jan 17, 2016·British Journal of Haematology·Kirsten Bleckmann, Martin Schrappe
Sep 14, 2010·Cancer Treatment Reviews·Heinz-Josef KlümpenHoward Gurney
Mar 17, 2010·Cancer Treatment Reviews·C Michel ZwaanUNKNOWN 'innovative therapies for children with cancer' European consortium
Feb 2, 2010·Hematology/oncology Clinics of North America·Rob Pieters, William L Carroll
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Jane Apperley
Oct 15, 2009·Hematology/oncology Clinics of North America·Farhad Ravandi, Partow Kebriaei
Sep 1, 2009·The American Journal of Pathology·Björn KoosMartin Hasselblatt
Jun 10, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sylvain BaruchelEric Bouffet
Apr 14, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Birgit GeoergerUNKNOWN Innovative Therapies for Children with Cancer European Consortium
Mar 3, 2009·Hematology/oncology Clinics of North America·Alberto S Pappo, Katherine A Janeway
Dec 23, 2008·Seminars in Hematology·Jules P P MeijerinkRob Pieters
Dec 23, 2008·Seminars in Hematology·Sima Jeha
Dec 10, 2015·Pediatrics International : Official Journal of the Japan Pediatric Society·Akihiko Tanizawa
Feb 5, 2008·Pediatric Clinics of North America·Rob Pieters, William L Carroll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.